Back

Editorial

Schwabe India has been witnessing visitors all the year round. But usually it used to be more during the last few months of the year. Last quarter of 2016 has witnessed good number of visitors. Apart from this news, coverage of Schwabe India’s participation in India International Trade Fair 2016 is under current news.

Cuscuta reflexa is a drug found in India. Its proving conducted by Central Council for Research in Homoeopathy (CCRH), India, has enriched the homoeopathic literature. This new drug has wide coverage on nervous system, digestion and musculo-skeletal system apart from other areas. Ephedra vulgaris is a drug covered by JH Clarke, A Blackwood, R Murphy, etc. It has been clinically verified by CCRH in multiple centres. These two drugs are covered under proving and clinical verification.

Mother tincture info contains Euphorbia lathyris and Asclepias tuberosa.  Euphorbia lathyris is mainly found in Europe whereas Asclepias tuberosa is from Americas and Africa. Former has coverage on skin, female and musculo-skeletal whereas the later has coverage on respiratory and digestive systems.

Schwabe India has recently launched some new products. Among them are Fucus vesiculosus 1x, Hertone and Dizester. Fucus vesiculosus 1x is for obesity management with thyroid disorders. Hertone and Dizester, as the names indicate, are for female and gastric problems respectively. Product watch gives brief introduction on these three products.

Research news focuses on a comparative study on ADHD, two retrospective studies on cancer treatment and asthma and a fundamental research on homoeopathic nanoparticle.

We tried to make this issue informative. Please give your feedbacks as always.

Dr. R. Valavan, BHMS, MD (Hom), MBA

Editor